Ian Cooper

Over the last 20 years, Ian Cooper has relied on a blend of technical, fundamental and news analysis with stocks, options, and ETFs. He was one of the few that called the bottom and top of housing, the top of sub prime and Alt-A, the death of Lehman Brothers and Bear Stearns, the collapse of the UK economy and the Dow’s collapse to 6,500, including its recovery. He even called for gold to rally well above $1,000 when it traded under $850. He’s shown thousands of investors just how to exploit “market extremes” for lightning fast, short-term gains with seven proprietary indicators that have led to successful calls on the biggest spikes and dips in the stock markets.

Read More

The CHEAP Investor

Since 1981, The CHEAP Investor newsletter has been an intelligent and straightforward guide to choosing low-price quality stocks and has helped thousands of investors make profitable investment decisions. Subscribers get the information that they need to purchase stocks with great profit potential at lowest...
Read More

Hercules Offshore, Inc. (HERO)

Today’s recommendation is entering turnaround territory, with increasing revenues, yet trading at a low valuation. Hercules Offshore, Inc. (HERO) from The Cheap Investor Hercules Offshore, Inc. (HERO) provides shallow-water drilling and marine services to the oil and natural gas exploration and production industry worldwide. Its services oil...
Read More

Curis, Inc. (CRIS)

Today’s pick is a biotech company with important alliances and a pipeline of drugs in clinical tests. Curis, Inc. (CRIS) from The Cheap Investor Curis, Inc. (CRIS) Curis has focused most of its internal resources on developing novel, proprietary small molecule targeted cancer drug candidates. Its principal is...
Read More

Solta Medical (SLTM)

Today’s Daily Alert features a new small-cap recommendation and an update on one of our Top Picks for 2013. Solta Medical (SLTM) from The Cheap Investor Solta Medical is a global leader in the medical aesthetics market providing ... aesthetic energy devices for skin resurfacing and acne...
Read More

Amicus Therapeutics (FOLD)

Today, The Cheap Investor Editor Bill Mathews recommends a low-priced, development-stage pharmaceutical company that is appropriate for speculative investors. Amicus Therapeutics (FOLD) Amicus Therapeutics, a biopharmaceutical company, focuses on the discovery, development, and commercialization of small molecule drugs known as pharmacological chaperones. ... The stock a..
Read More

ArQule, Inc. (ARQL)

Today’s Daily Alert brings a new low-priced pharmaceutical stock idea from The CHEAP Investor. “ArQule, Inc. (ARQL) engages in the research and development of cancer therapeutics directed toward molecular targets and biological processes. Its lead product candidate tivantinib (ARQ 197) is an inhibitor of c-Met...
Read More